News Author: HT Staff Publish date: March 10, 2016
The US Food and Drug Administration (FDA) has lifted the partial clinical hold on the investigational new drug (IND) application for pidilizumab (MDV9...
News Author: HT Staff Publish date: March 10, 2016
Photo by Nina Matthews
A 2-drug prophylactic regimen can reduce the risk of Plasmodium falciparum malaria during pregnancy, according to a study pu...
News Author: HT Staff Publish date: March 9, 2016
Image by Andre E.X.
News Author: HT Staff Publish date: March 9, 2016
Photo courtesy of
The Ottawa Hospital
An experimental compound is “highly promising” as a potential treatment for a subtype of T-cell acute lympho...
News Author: HT Staff Publish date: March 9, 2016
Image by Matthias Zepper
Researchers have reportedly identified precursor cells that can be matured into transplantable hematopoietic stem/progenit...
News Author: HT Staff Publish date: March 9, 2016
Image courtesy of NIAID
A new tool can help scientists determine how different types of T cells detect, destroy, and remember antigens, according t...
News Author: HT Staff Publish date: March 8, 2016
A dual kinase inhibitor has shown early promise as a potential treatment for multiple myeloma (MM), according to investigators.
The inhibitor, ON12...
News Author: HT Staff Publish date: March 8, 2016
and a normal one
Image by Betty Pace
A microfluidic system can measure the deformability and adhesion of red blood cells (RBCs) in samples from pa...
News Author: HT Staff Publish date: March 8, 2016
in the intensive care unit
New data from the US Centers for Disease Control and Prevention (CDC) suggest the incidence of certain healthcare-associ...
News Author: HT Staff Publish date: March 8, 2016
Photo courtesy of the FDA
The European Medicines Agency (EMA) has launched PRIME (PRIority MEdicines), an initiative intended to accelerate the dev...
News Author: HT Staff Publish date: March 7, 2016
Photo by Vera Kratochvil
Researchers say they have discovered significant differences between blood clot structure in adults and newborns, a findin...
News Author: HT Staff Publish date: March 7, 2016
Photo by Aaron Logan
New research suggests hematologic malignancies driven by MYC might be prevented by lowering levels of another protein, MCL-1.
...
News Author: HT Staff Publish date: March 6, 2016
The product—a fusion protein linking recombinant coagulation factor IX with recombinant albumin—is intended for use in children and adults for routine...
News Author: HT Staff Publish date: March 5, 2016
Photo courtesy of Janssen
The US Food and Drug Administration (FDA) has approved the BTK inhibitor ibrutinib (Imbruvica) as a first-line treatment ...
News Author: HT Staff Publish date: March 4, 2016
acute lymphoblastic leukemia
Image by Hind Medyouf
Breaches in looping chromosomal structures known as insulated neighborhoods can activate oncoge...
